Alset Inc. operates as a diversified holding company with principal businesses in U.S.-based real estate development, B2B digital transformation technologies, and biohealth consumer products. The company experienced a sharp increase in net losses and deteriorating operating cash flows through 2025. A persistent internal control weakness related to staffing elevates risks around financial reporting accuracy amid intensifying competition and regulatory demands across its core segments. Capital allocation reflects ongoing challenges with negative returns despite sizable share repurchases executed in prior periods.